BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 27272311)

  • 1. Multiple myeloma cells promote migration of bone marrow mesenchymal stem cells by altering their translation initiation.
    Dabbah M; Attar-Schneider O; Zismanov V; Tartakover Matalon S; Lishner M; Drucker L
    J Leukoc Biol; 2016 Oct; 100(4):761-770. PubMed ID: 27272311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple myeloma and bone marrow mesenchymal stem cells' crosstalk: Effect on translation initiation.
    Attar-Schneider O; Zismanov V; Dabbah M; Tartakover-Matalon S; Drucker L; Lishner M
    Mol Carcinog; 2016 Sep; 55(9):1343-54. PubMed ID: 26293751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cells secretomes' affect multiple myeloma translation initiation.
    Marcus H; Attar-Schneider O; Dabbah M; Zismanov V; Tartakover-Matalon S; Lishner M; Drucker L
    Cell Signal; 2016 Jun; 28(6):620-30. PubMed ID: 26976208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migration and epithelial-to-mesenchymal transition of lung cancer can be targeted via translation initiation factors eIF4E and eIF4GI.
    Attar-Schneider O; Drucker L; Gottfried M
    Lab Invest; 2016 Sep; 96(9):1004-15. PubMed ID: 27501049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BM-MSCs-derived ECM modifies multiple myeloma phenotype and drug response in a source-dependent manner.
    Ibraheem A; Attar-Schneider O; Dabbah M; Dolberg Jarchowsky O; Tartakover Matalon S; Lishner M; Drucker L
    Transl Res; 2019 May; 207():83-95. PubMed ID: 30738861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secretome of human bone marrow mesenchymal stem cells: an emerging player in lung cancer progression and mechanisms of translation initiation.
    Attar-Schneider O; Zismanov V; Drucker L; Gottfried M
    Tumour Biol; 2016 Apr; 37(4):4755-65. PubMed ID: 26515338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvesicles derived from normal and multiple myeloma bone marrow mesenchymal stem cells differentially modulate myeloma cells' phenotype and translation initiation.
    Dabbah M; Attar-Schneider O; Tartakover Matalon S; Shefler I; Jarchwsky Dolberg O; Lishner M; Drucker L
    Carcinogenesis; 2017 Jul; 38(7):708-716. PubMed ID: 28838065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting eIF4GI translation initiation factor affords an attractive therapeutic strategy in multiple myeloma.
    Attar-Schneider O; Drucker L; Zismanov V; Tartakover-Matalon S; Lishner M
    Cell Signal; 2014 Sep; 26(9):1878-87. PubMed ID: 24815186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribosomal proteins as distinct "passengers" of microvesicles: new semantics in myeloma and mesenchymal stem cells' communication.
    Dabbah M; Lishner M; Jarchowsky-Dolberg O; Tartakover-Matalon S; Brin YS; Pasmanik-Chor M; Neumann A; Drucker L
    Transl Res; 2021 Oct; 236():117-132. PubMed ID: 33887527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region.
    Berenstein R; Blau O; Nogai A; Waechter M; Slonova E; Schmidt-Hieber M; Kunitz A; Pezzutto A; Doerken B; Blau IW
    BMC Cancer; 2015 Feb; 15():68. PubMed ID: 25886144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Translation Initiation Factor eIF4E Is an Attractive Therapeutic Target in Multiple Myeloma.
    Li S; Fu J; Lu C; Mapara MY; Raza S; Hengst U; Lentzsch S
    Mol Cancer Ther; 2016 Apr; 15(4):711-9. PubMed ID: 26939700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple myeloma cells modify VEGF/IL-6 levels and osteogenic potential of bone marrow stromal cells via Notch/miR-223.
    Berenstein R; Nogai A; Waechter M; Blau O; Kuehnel A; Schmidt-Hieber M; Kunitz A; Pezzutto A; Dörken B; Blau IW
    Mol Carcinog; 2016 Dec; 55(12):1927-1939. PubMed ID: 27023728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche.
    Colombo M; Galletti S; Bulfamante G; Falleni M; Tosi D; Todoerti K; Lazzari E; Crews LA; Jamieson CH; Ravaioli S; Baccianti F; Garavelli S; Platonova N; Neri A; Chiaramonte R
    Oncotarget; 2016 Aug; 7(35):56013-56029. PubMed ID: 27463014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. eIF4E and eIF4GI have distinct and differential imprints on multiple myeloma's proteome and signaling.
    Attar-Schneider O; Pasmanik-Chor M; Tartakover-Matalon S; Drucker L; Lishner M
    Oncotarget; 2015 Feb; 6(6):4315-29. PubMed ID: 25717031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RANKL expression in myeloma cells is regulated by a network involving RANKL promoter methylation, DNMT1, microRNA and TNFα in the microenvironment.
    Yuan L; Chan GC; Fung KL; Chim CS
    Biochim Biophys Acta; 2014 Sep; 1843(9):1834-8. PubMed ID: 24875904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Interference in the Bone Marrow Microenvironment by Disseminated Breast Cancer Cells.
    Dhawan A; von Bonin M; Bray LJ; Freudenberg U; Pishali Bejestani E; Werner C; Hofbauer LC; Wobus M; Bornhäuser M
    Stem Cells; 2016 Aug; 34(8):2224-35. PubMed ID: 27090603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche.
    Tsukamoto S; Løvendorf MB; Park J; Salem KZ; Reagan MR; Manier S; Zavidij O; Rahmat M; Huynh D; Takagi S; Kawano Y; Kokubun K; Thrue CA; Nagano K; Petri A; Roccaro AM; Capelletti M; Baron R; Kauppinen S; Ghobrial IM
    Leukemia; 2018 Aug; 32(8):1739-1750. PubMed ID: 29925904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow mesenchymal stem cells regulate stemness of multiple myeloma cell lines via BTK signaling pathway.
    Zhao P; Chen Y; Yue Z; Yuan Y; Wang X
    Leuk Res; 2017 Jun; 57():20-26. PubMed ID: 28273548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulation.
    Wang X; Li C; Ju S; Wang Y; Wang H; Zhong R
    Leuk Lymphoma; 2011 Oct; 52(10):1991-8. PubMed ID: 21718132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectopic expression of BIRC5-targeting miR-101-3p overcomes bone marrow stroma-mediated drug resistance in multiple myeloma cells.
    Abdi J; Rastgoo N; Chen Y; Chen GA; Chang H
    BMC Cancer; 2019 Oct; 19(1):975. PubMed ID: 31638931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.